Five things to know:
1. Total revenue rose 12 percent year over year.
2. Conformis’ hip system revenue reached $0.8 million, an 18 percent year-over-year jump.
3. The company saw an increased net loss of $16 million. In 2021, first-quarter net loss was $11.5 million.
4. An increase of product revenue was credited to “modest recovery” in elective procedures compared to the same time last year.
5. The company expects second-quarter revenue to be $14.5 million-$15.5 million, and full-year revenue is expected to be $75 million-$81 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
